TY - JOUR
T1 - Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe
AU - Adamson, Peter
AU - Bray, Freddie
AU - Costantini, Adele Seniori
AU - Tao, Meng Hua
AU - Weiderpass, Elisabete
AU - Roman, Eve
N1 - Funding Information:
This study was part of the Comprehensive Cancer Monitoring Programme in Europe (CaMon) project funded by the European Commission, Agreement No. Sl2.327599 (2001CVG3–512). The following European cancer registries (Director in parentheses) are participating investigators, having contributed their incidence data, as well as their expertise in commenting on the final manuscript: Czech Republic – Czech National Cancer Registry, Prague (Dr. Jana Ajmová); Denmark – Danish Cancer Society, Copenhagen (Dr. Hans H. Storm); Finland – Finnish Cancer Registry, Helsinki (Dr. Timo Hakulinen); France – Registre Bas Rhinois des Cancers, Strasbourg (Dr. Michel Velten), Registre Général des Tumeurs du Calvados, Caen (Dr. J. Macé-Lesech), Registre des Tumeurs du Doubs, Besançon (Dr. Arlette Danzon), Registre du Cancer de l’Isère, Meylan (Dr. Marc Colonna), Registre du Cancer de la Somme, Amiens (Mme Nicole Raverdy), Registre des Cancers du Tarn, Albi (Dr. Martine Sauvage); Ireland – National Cancer Registry, Cork (Dr. Harry Comber); Italy – Registro Tumori Toscano, Florence (Dr. Eugenio Paci), Registro Tumori Lombardia (Provincia di Varese), Milan (Dr. Paolo Crosignani), Registro Tumori della Provincia di Parma (Dr. Vincenzo De Lisi), Registro Tumori della Provincia di Ragusa, Ragusa (Dr. Rosario Tumino), Piedmont Cancer Registry, Turin (Dr. Roberto Zanetti); Norway – Cancer Registry of Norway, Oslo (Dr. Frøydis Langmark); Slovakia – Slovakia-National Cancer Registry of the Slovak Republic, Bratislava (Dr. Martina Ondrusova, Dr. Ivan Plesko); Slovenia – Cancer Registry of Slovenia, Ljubljana (Dr. Maja Primic-Zakelj); Spain – Tarragona Cancer Registry, Reus (Dr. Jaume Galceran), Registro de Cáncer de Granada, Granada (Dr. Carmen Martínez Garcia), Registro de Cáncer de Murcia, Murcia (Dr. Carmen Navarro Sánchez), Registro de Cáncer de Navarra, Pamplona (Dr. E. Ardanaz Aicua), Zaragoza Cancer Registry, Zaragoza (Dr. Carmen Martos Jimenez); Sweden – Swedish Cancer Registry, Stockholm (Dr. Lotti Barlow); Switzerland – Krebsregister Basel-Stadt und Basel-Land, Basle (Dr. Gernot Jundt), Registre Genevois des Tumeurs, Geneva (Dr. Christine Bouchardy), Registre Neuchâtelois des Tumeurs, Neuchâtel (Dr. Fabio Levi), Krebsregister St. Gallen Appenzell, St. Gallen (Dr. Silvia Ess), Registre Vaudois des Tumeurs, Lausanne (Dr. Fabio Levi), Kantonalzürcherisches Krebsregister, Zürich (Dr. Nicole Probst); United Kingdom – Eastern Cancer Registration and Information Centre, Cambridge (Jem Rashbass), North West Cancer Intelligence Service, Manchester (Tony Moran), Northern and Yorkshire Cancer Registry and Information Service, Leeds (David Forman), Oxford Cancer Intelligence Unit, Oxford (Monica Roche); South and West Cancer Intelligence Service, Bristol (Julia Verne), Thames Cancer Registry (Henrik Moller); Trent Cancer Registry, Sheffield (David Meechan), West Midlands Cancer Intelligence Unit, Birmingham (Gill Lawrence), Scottish Cancer Registry, Edinburgh (Dr. David Brewster).
PY - 2007/1
Y1 - 2007/1
N2 - Lymphoma incidence is reported to be increasing globally. If real, these trends can only be explained by an increasing exposure to risk(s) as yet unknown. There have been numerous coding and classification changes over time and greater access to ever more sensitive diagnostic tests. It is important to understand the consequences that these changes, coupled with general improvements in cancer registration, have had on observed temporal trends. Trends in the registration rates of both non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) in Europe are presented. Age-adjusted and age-specific rates are described in men and women in 13 European countries according to both period of diagnosis and year of birth. Age, period and cohort effects are modelled. Overall, there are increases in the numbers of NHL registrations made with a corresponding decrease in HL. In recent history, however, there is a suggestion that the rate of increase is less and stable.
AB - Lymphoma incidence is reported to be increasing globally. If real, these trends can only be explained by an increasing exposure to risk(s) as yet unknown. There have been numerous coding and classification changes over time and greater access to ever more sensitive diagnostic tests. It is important to understand the consequences that these changes, coupled with general improvements in cancer registration, have had on observed temporal trends. Trends in the registration rates of both non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) in Europe are presented. Age-adjusted and age-specific rates are described in men and women in 13 European countries according to both period of diagnosis and year of birth. Age, period and cohort effects are modelled. Overall, there are increases in the numbers of NHL registrations made with a corresponding decrease in HL. In recent history, however, there is a suggestion that the rate of increase is less and stable.
KW - Epidemiology
KW - Lymphoma
KW - Population-based
KW - Registries
UR - http://www.scopus.com/inward/record.url?scp=33846499645&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2006.10.008
DO - 10.1016/j.ejca.2006.10.008
M3 - Article
C2 - 17134891
AN - SCOPUS:33846499645
SN - 0959-8049
VL - 43
SP - 391
EP - 401
JO - European Journal of Cancer
JF - European Journal of Cancer
IS - 2
ER -